Device Trial Radar · NCT07932080
Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) Patients With Left Ventricular Dysfunction (LVD).
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
116
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Dec 2027
Study completion Dec 2029
Sponsor
- Lead sponsor
- CHC MontlegiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to define a correlation between the number of microembolic signals (MES) detected by the transcranial doppler and the risk of occurrence of an Acute Ischemic Stroke (AIS) at 2 years or a Left Ventricular Thrombus (LVT) at 6 weeks.
Conditions
- STEMI
- Left Ventricular Thrombus
- Acute Ischemic Stroke
Interventions
Transcranial doppler (TCD)Device
A TCD with MES detection will be performed the day of the inclusion. Another TCD will be performed at 6 weeks of the inclusion. Patients will then receive a follow-up call at one year, followed by a final visit two years after inclusion, blinded to the results of the TCD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Demonstration of a correlation between the number of MES detected and the 2-year risk of AIS or the occurrence of a LVT at 6 weeks in patients with post-STEMI LVD.Time frame: To the enrollment period to 2-years of AIS or 6-weeks of a LVT
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHC MontLégia
Liège, Liège, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.